BANK VONTOBEL/CALL/PFIZER INC/28/0.1/20.12.24 Stock

Warrant

DE000VM8GNS3

Delayed Deutsche Boerse AG 04:22:51 2024-07-04 EDT
0.166 EUR +5.06% Intraday chart for BANK VONTOBEL/CALL/PFIZER INC/28/0.1/20.12.24
Current month-10.73%
1 month-41.48%
Date Price Change
24-07-04 0.166 +5.06%
24-07-03 0.158 -5.95%
24-07-02 0.168 -13.40%
24-07-01 0.194 +9.60%
24-06-28 0.177 +4.12%

Delayed Quote Deutsche Boerse AG

Last update July 04, 2024 at 04:22 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying PFIZER, INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VM8GNS
ISINDE000VM8GNS3
Date issued 2024-01-12
Strike 28 $
Maturity 2024-12-20 (170 Days)
Parity 10 : 1
Emission price 0.29
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 0.3
Lowest since issue 0.11
Spread 0.01
Spread %5.56%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
27.7 USD
Average target price
31.92 USD
Spread / Average Target
+15.22%
Consensus